These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 217731)

  • 1. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of platelet aggregation and adenosine 3':5'-monophosphate on the synthesis of thromboxane B2 in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    Adv Prostaglandin Thromboxane Res; 1980; 6():275-81. PubMed ID: 6247886
    [No Abstract]   [Full Text] [Related]  

  • 3. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 5. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
    Burns GB; Dodge JA
    Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
    Miller OV; Ayer DE; Gorman RR
    Biochim Biophys Acta; 1982 Jun; 711(3):445-51. PubMed ID: 6285985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin.
    Gorman RR; Fitzpatrick FA; Miller OV
    Adv Cyclic Nucleotide Res; 1978; 9():597-609. PubMed ID: 208399
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 11. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 12. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
    Vericel E; Lagarde M
    Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence on thromboxane and malondialdehyde synthesis in human thrombocytes by various inhibitors of platelet function.
    Busse WD; Seuter F
    Agents Actions Suppl; 1979; (4):127-37. PubMed ID: 291303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of three vasodilating agents as selective inhibitors of thromboxane A2 biosynthesis.
    Greenwald JE; Wong LK; Rao M; Bianchine JR; Panganamala RV
    Biochem Biophys Res Commun; 1978 Oct; 84(4):1112-8. PubMed ID: 728149
    [No Abstract]   [Full Text] [Related]  

  • 15. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
    Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
    Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
    Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostacyclin-dependent differences in TXA2 formation by platelets from normal and atherosclerotic rabbits.
    Dembińska-Kièć A; Rücker W; Schönhöfer PS
    Atherosclerosis; 1979 Jun; 33(2):217-26. PubMed ID: 224890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of prostaglandins, thromboxanes and prostacyclin in regulating the thrombocyte aggregation process and liberation reaction normally and in pathology].
    Baluda VP; Sushkevich GN; Lukoianova TI
    Patol Fiziol Eksp Ter; 1980; (4):80-5. PubMed ID: 6251418
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of an inhibitor of TXA2 synthesis and of PGE2 on the formation of 12-L-hydroxy-5,8,10-heptadecatrienoic acid in human platelets.
    Vincent JE; Zijlstra FJ; van Vliet H
    Adv Prostaglandin Thromboxane Res; 1980; 6():463-6. PubMed ID: 7386279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.